Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide

M. E. Astiz, Dhanonjoy C. Saha, K. Brooks, C. M. Carpati, E. C. Rackow

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We compared the induction of endotoxin tolerance with Salmonella minnesota monophosphoryl lipid A (MPL), a nontoxic derivative of lipid A, and S. minnesota endotoxin (LPS) in lethal endotoxemia and peritonitis. Lethal endotoxemia was induced by injecting 750 μg/mouse LPS intravenously. Cecal ligation and perforation was used to induce peritonitis. Tumor necrosis factor (TNF) was measured by immunoassay at 2 hr after lethal endotoxin infusion and 24 hr after peritonitis. A dose of 0.1 μg/mouse of MPL or LPS significantly reduced endotoxin mortality from 100% to 50% and 27%, respectively (P <0.05). The LD50 for a 0.1 μg dose of MPL was 750 μg of LPS and the LD50 for a 0.1 μg dose of LPS was 1150 μg of endotoxin (P <0.05). TNF levels decreased linearly when increasing doses of MPL and LPS were used to induce tolerance. At higher pretreatment doses of LPS, survival benefits were attenuated despite the reduction in TNF levels. A 25 μg dose of LPS reduced mortality from peritonitis from 93% to 45% (P <0.05). Although MPL reduced short-term mortality, overall mortality was not significantly reduced despite using large doses of MPL. TNF levels peaked at 24 hr and were significantly lower than those following lethal endotoxemia. The induction of endotoxin tolerance by LPS and MPL is dose dependent, and LPS is modestly more effective in inducing endotoxin tolerance than MPL. Both LPS and MPL are significantly less effective in protecting against lethality from peritonitis.

Original languageEnglish (US)
Pages (from-to)194-198
Number of pages5
JournalCirculatory Shock
Volume39
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Endotoxemia
Peritonitis
Endotoxins
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Mortality
Lethal Dose 50
monophosphoryl lipid A
Lipid A
Immunoassay
Salmonella
Ligation

Keywords

  • cytokines
  • immunomodulator
  • sepsis
  • tumor necrosis factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. / Astiz, M. E.; Saha, Dhanonjoy C.; Brooks, K.; Carpati, C. M.; Rackow, E. C.

In: Circulatory Shock, Vol. 39, No. 3, 1993, p. 194-198.

Research output: Contribution to journalArticle

@article{7fa635da8a1643799f826682298cb4a5,
title = "Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide",
abstract = "We compared the induction of endotoxin tolerance with Salmonella minnesota monophosphoryl lipid A (MPL), a nontoxic derivative of lipid A, and S. minnesota endotoxin (LPS) in lethal endotoxemia and peritonitis. Lethal endotoxemia was induced by injecting 750 μg/mouse LPS intravenously. Cecal ligation and perforation was used to induce peritonitis. Tumor necrosis factor (TNF) was measured by immunoassay at 2 hr after lethal endotoxin infusion and 24 hr after peritonitis. A dose of 0.1 μg/mouse of MPL or LPS significantly reduced endotoxin mortality from 100{\%} to 50{\%} and 27{\%}, respectively (P <0.05). The LD50 for a 0.1 μg dose of MPL was 750 μg of LPS and the LD50 for a 0.1 μg dose of LPS was 1150 μg of endotoxin (P <0.05). TNF levels decreased linearly when increasing doses of MPL and LPS were used to induce tolerance. At higher pretreatment doses of LPS, survival benefits were attenuated despite the reduction in TNF levels. A 25 μg dose of LPS reduced mortality from peritonitis from 93{\%} to 45{\%} (P <0.05). Although MPL reduced short-term mortality, overall mortality was not significantly reduced despite using large doses of MPL. TNF levels peaked at 24 hr and were significantly lower than those following lethal endotoxemia. The induction of endotoxin tolerance by LPS and MPL is dose dependent, and LPS is modestly more effective in inducing endotoxin tolerance than MPL. Both LPS and MPL are significantly less effective in protecting against lethality from peritonitis.",
keywords = "cytokines, immunomodulator, sepsis, tumor necrosis factor",
author = "Astiz, {M. E.} and Saha, {Dhanonjoy C.} and K. Brooks and Carpati, {C. M.} and Rackow, {E. C.}",
year = "1993",
language = "English (US)",
volume = "39",
pages = "194--198",
journal = "Journal of inflammation",
issn = "1078-7852",
publisher = "BioMed Central",
number = "3",

}

TY - JOUR

T1 - Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide

AU - Astiz, M. E.

AU - Saha, Dhanonjoy C.

AU - Brooks, K.

AU - Carpati, C. M.

AU - Rackow, E. C.

PY - 1993

Y1 - 1993

N2 - We compared the induction of endotoxin tolerance with Salmonella minnesota monophosphoryl lipid A (MPL), a nontoxic derivative of lipid A, and S. minnesota endotoxin (LPS) in lethal endotoxemia and peritonitis. Lethal endotoxemia was induced by injecting 750 μg/mouse LPS intravenously. Cecal ligation and perforation was used to induce peritonitis. Tumor necrosis factor (TNF) was measured by immunoassay at 2 hr after lethal endotoxin infusion and 24 hr after peritonitis. A dose of 0.1 μg/mouse of MPL or LPS significantly reduced endotoxin mortality from 100% to 50% and 27%, respectively (P <0.05). The LD50 for a 0.1 μg dose of MPL was 750 μg of LPS and the LD50 for a 0.1 μg dose of LPS was 1150 μg of endotoxin (P <0.05). TNF levels decreased linearly when increasing doses of MPL and LPS were used to induce tolerance. At higher pretreatment doses of LPS, survival benefits were attenuated despite the reduction in TNF levels. A 25 μg dose of LPS reduced mortality from peritonitis from 93% to 45% (P <0.05). Although MPL reduced short-term mortality, overall mortality was not significantly reduced despite using large doses of MPL. TNF levels peaked at 24 hr and were significantly lower than those following lethal endotoxemia. The induction of endotoxin tolerance by LPS and MPL is dose dependent, and LPS is modestly more effective in inducing endotoxin tolerance than MPL. Both LPS and MPL are significantly less effective in protecting against lethality from peritonitis.

AB - We compared the induction of endotoxin tolerance with Salmonella minnesota monophosphoryl lipid A (MPL), a nontoxic derivative of lipid A, and S. minnesota endotoxin (LPS) in lethal endotoxemia and peritonitis. Lethal endotoxemia was induced by injecting 750 μg/mouse LPS intravenously. Cecal ligation and perforation was used to induce peritonitis. Tumor necrosis factor (TNF) was measured by immunoassay at 2 hr after lethal endotoxin infusion and 24 hr after peritonitis. A dose of 0.1 μg/mouse of MPL or LPS significantly reduced endotoxin mortality from 100% to 50% and 27%, respectively (P <0.05). The LD50 for a 0.1 μg dose of MPL was 750 μg of LPS and the LD50 for a 0.1 μg dose of LPS was 1150 μg of endotoxin (P <0.05). TNF levels decreased linearly when increasing doses of MPL and LPS were used to induce tolerance. At higher pretreatment doses of LPS, survival benefits were attenuated despite the reduction in TNF levels. A 25 μg dose of LPS reduced mortality from peritonitis from 93% to 45% (P <0.05). Although MPL reduced short-term mortality, overall mortality was not significantly reduced despite using large doses of MPL. TNF levels peaked at 24 hr and were significantly lower than those following lethal endotoxemia. The induction of endotoxin tolerance by LPS and MPL is dose dependent, and LPS is modestly more effective in inducing endotoxin tolerance than MPL. Both LPS and MPL are significantly less effective in protecting against lethality from peritonitis.

KW - cytokines

KW - immunomodulator

KW - sepsis

KW - tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0027410625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027410625&partnerID=8YFLogxK

M3 - Article

C2 - 8453743

AN - SCOPUS:0027410625

VL - 39

SP - 194

EP - 198

JO - Journal of inflammation

JF - Journal of inflammation

SN - 1078-7852

IS - 3

ER -